[KTTA] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
14-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 23.51%
YoY- 98.60%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 CAGR
Revenue 0 0 14 0 -
PBT -3,861 -3,266 -1,574 -550 91.36%
Tax 0 271,869 -1,616 0 -
NP -3,861 -275,135 41 -550 91.36%
Tax Rate - - - - -
Total Cost 3,861 275,135 -28 550 91.36%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 CAGR
NP Margin 0.00 0.00 302.78 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 CAGR
EPS -3.70 -211.05 0.00 -0.04 351.62%
EPS Diluted -3.70 -211.05 0.00 -0.04 351.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.